Raflodic S-Aq

Raflodic S-Aq Injection injection should only be given by a healthcare professional. It can be given deep into the muscle (intramuscularly), preferably in buttock, under the skin (subcutaneously), or directly into a vein (intravenously) as a bolus and not as infusion. The dose should not exceed the prescribed quantity and injection should not be given for more than 2 days.

It is important to know that Raflodic S-Aq Injection may increase your chance of having a heart attack or stroke. The risk is more if you take higher doses and have been using the medicine for a longer time. Also, taking Raflodic S-Aq Injection may cause ulcers, bleeding, or holes in your stomach and intestine. These problems may happen without warning symptoms at any time during treatment and may even cause death. Therefore, if you encounter any such problems, consult your doctor immediately.

Raflodic S-Aq Injection is effective in relieving pain and inflammation. It is used for various sorts of pain such as sprains, strains and other injuries. It is also helpful in various types of arthritis, gout, pain and inflammation following surgery.

Long-term use and high doses of Raflodic S-Aq Injection may cause renal problems such as protein or blood in urine and painful urination. Patients who are at maximum risk of developing kidney problems include people who are dehydrated, have heart failure, impaired kidney function, hypertension, elderly, who are on medicines which cause excess urination (diuretics), or medicines which have significant impact on kidney function. Hence, for such patients kidney function monitoring is recommended.

Raflodic S-Aq Injection can cause drowsiness and also dizziness, fatigue (tiredness) and visual disturbances. However, it is not very common and may not affect everyone. If you experience these symptoms avoid driving or operating heavy machinery.

You should not take Raflodic S-Aq Injection during the last 3 months of pregnancy as it may cause harmful effects on your baby. Use of Raflodic S-Aq Injection can also lead to reduced labor (premature delivery). Hence, it is advised to avoid using Raflodic S-Aq Injection during the first 6 months of pregnancy also. In some cases, Raflodic S-Aq Injection may be prescribed in pregnant women only if the benefits outweigh the risks involved with its use in pregnant women. If not sure, consult your doctor regarding its use.

No, Raflodic S-Aq Injection does not get you high. It does not have an abuse potential (drug-seeking behavior) and does not cause physical or psychological dependence. However, if you do not feel well, consult your doctor.

No, Raflodic S-Aq Injection is not a narcotic. It belongs to non-steroidal anti-inflammatory drugs (NSAIDs) group of medicines.